Healing of chronic venous ulcer with topical sevoflurane
Autor: | Isabel Portero-Sanchez, Mónica Sanjuan-Alvarez, Raúl Merinero-Palomares, Francisco Javier Ortiz-de Frutos, Victoria Alcazar, Adrian Imbernon-Moya |
---|---|
Rok vydání: | 2017 |
Předmět: |
Analgesic effect
medicine.medical_specialty Erythema business.industry medicine.medical_treatment Analgesic Retrospective cohort study Dermatology 030204 cardiovascular system & hematology Sevoflurane Surgery 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Refractory Anesthesia medicine medicine.symptom Adverse effect business Saline medicine.drug |
Zdroj: | International Wound Journal. 14:1323-1326 |
ISSN: | 1742-4801 |
DOI: | 10.1111/iwj.12806 |
Popis: | The present study assesses the efficacy and safety of topical sevoflurane in chronic venous ulcers and its impact on analgesia and healing. This retrospective study included 30 patients older than 65 years with painful refractory chronic venous ulcers. Patients were treated with topical sevoflurane prior to the usual ulcer cleaning every 2 days for a period of 1 month. Treatment was initiated with a saline solution, followed by direct irrigation of 1 ml of liquid sevoflurane over the wound size, which was measured as cm2 . Sevoflurane had a fast, intense and long-lasting analgesic effect. Latency time ranged from 2 to 7 minutes (3·9 ± 1·5 minutes), and duration varied from 8 to 18 hours (12 ± 2·9). The mean ulcer size was 8·4 ± 9·7 cm2 . There was a progressive decrease in size in all patients, with a mean size of 4·2 ± 5·4 cm2 at the end of the study. There were no adverse systemic effects. Local adverse effects were mild and transient, including pruritus, erythema and heat. Topical sevoflurane is a new, efficient and safe therapeutic alternative in painful chronic venous ulcers, refractory to usual analgesic treatment. It can improve the ulcer-healing process that shortens the cicatrisation period. |
Databáze: | OpenAIRE |
Externí odkaz: |